Experienced Executive Director with a demonstrated history of achievements in the pharmaceutical and biotechnology industry. Skilled in clinical trial design, biostatistics, drug development strategies. Profound understanding of U.S. Food and Drug Administration (FDA), European EMEA, and Japan PMDA etc. regulatory agencies' drug approval requirements and philosophies. Strong professional with a Ph.D. in Statistics from North Carolina State University.

• 

  Chief Strategy Officer (CSO) in Rapid Novor

  Antibody Discovery and Characterization Services Powered by Mass Spectrometry.